- SID Score
- 6.0/10
- Fair value
- $179.91
- Generated
- Aug 26, 2026
- Model
- claude-haiku-4-5-20251001
IBM is trading at $229.98 with a market capitalization of $290.3 billion, but appears overvalued relative to its fundamentals based on a fair value estimate of $179.91, suggesting 23.7% downside risk. The company's SID Score of 6.0/10 reflects mixed quality metrics, with particular weakness in Value (F) and Growth (F) grades, though Profitability and Momentum scores of C indicate stability in core operations. Analyst consensus remains bullish with an average price target of $293.86, creating a notable disconnect between professional recommendations and intrinsic valuation models.
IBM's valuation metrics present significant concerns, with a P/E ratio of 36.68 substantially elevated for a mature technology company with limited growth prospects, as evidenced by its F-grade in the Growth category. The company demonstrates middling profitability (C grade) and generates minimal shareholder returns with only a 0.02% dividend yield, reflecting limited capital returned to investors. Recent earnings results show mixed performance with a miss on July 22 (EPS of $2.93 vs. estimate of $3.02), though the prior quarter exceeded expectations with $4.52 actual versus $4.31 estimated, suggesting inconsistent execution and earnings quality concerns.
IBM's technical position indicates weakness, with the stock trading significantly below its 200-day moving average of $259.25 and moderately below the 50-day moving average of $246.48, confirming a downtrend in price momentum. The RSI(14) of 44.9 sits just above oversold territory (below 30), suggesting the stock may be approaching support levels but lacks clear momentum for a sustained rally. The $50 gap between current price ($229.98) and the analyst price target ($293.86) appears optimistic given the deteriorating technical backdrop and distance from key moving averages.
Analyst & Insider Sentiment
Despite maintaining a "Buy" consensus rating with a $293.86 average price target, analyst recommendations conflict with the company's weak fundamental grades and fair value estimate, raising questions about the basis for bullish calls. Recent insider activity from director Anne Robinson reveals complex trading patterns on July 1, 2026, including multiple large sell transactions (totaling approximately 35,373 shares sold) followed by a single buy of 14,429 shares, suggesting cautious or net-negative conviction from insiders. The heavy insider selling relative to buying could indicate limited confidence in the stock's valuation at current levels, contradicting the "Buy" consensus.
The primary valuation risk is that IBM's current price of $229.98 already incorporates optimistic growth expectations, with limited margin of safety given the 36.68 P/E ratio and fair value estimate suggesting 23.7% downside exposure. Earnings execution risk remains evident, as the company missed EPS expectations in the most recent quarter, indicating potential challenges in meeting market consensus estimates moving forward. Additionally, the technology sector's competitive dynamics and IBM's F-grades in both Value and Growth categories suggest structural headwinds that may limit future capital appreciation and justify lower valuations.
IBM represents a conflicted investment opportunity where analyst bullishness and near-term price targets clash with deteriorating fundamentals, technical weakness, and insider selling pressure, making it unsuitable for value-oriented investors at current levels. The company would be more attractive at the fair value estimate of $179.91 (approximately 22% below current price), providing a meaningful margin of safety and more appropriate valuation relative to its C-grade profitability profile and weak growth trajectory. Conservative investors should wait for a more significant pullback or seek higher-quality alternatives with stronger growth prospects and superior value metrics, particularly given the mixed earnings track record and limited dividend income.
